Tq Therapeutics

TQx is delivering safe in vivo cell & gene therapies to make challenging diseases curable – for everyone TQ Therapeutics is offering their CELLfinity platform, a modular target cell-specific modification platform for the generation of infinite in vivo cell & gene therapy product opportunities. The modular platform is based on TQx‘s proprietary EXiVO approach - an extracorporeal in-vivo gene therapy. This new generation of autologous mRNA-T-cell therapeutics are designed to revolutionize several treatment areas across indications, without abandoning the advantages of safe autologous cell therapy